Rock Springs Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Rock Springs Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-288,279	Closed	-$18.2M	–	160
2020 Q2	$18.2M	Buy	288,279 +8,279	+3%	+$568K	0.5%	69
2020 Q1	$14.3M	Buy	280,000 +15,000	+6%	+$1M	0.59%	57
2019 Q4	$21.1M	Hold	265,000	–	–	0.67%	60
2019 Q3	$12.9M	Hold	265,000	–	–	0.51%	63
2019 Q2	$13.9M	Buy	265,000 +20,000	+8%	+$1.15M	0.5%	67
2019 Q1	$13M	Hold	245,000	–	–	0.5%	67
2018 Q4	$10.1M	Buy	245,000 +95,000	+63%	+$3.56M	0.47%	68
2018 Q3	$5.7M	Hold	150,000	–	–	0.21%	111
2018 Q2	$6.78M	Hold	150,000	–	–	0.26%	105
2018 Q1	$7.25M	Hold	150,000	–	–	0.31%	96
2017 Q4	$5.9M	Hold	150,000	–	–	0.27%	101
2017 Q3	$4.66M	Hold	150,000	–	–	0.21%	105
2017 Q2	$4.1M	Hold	150,000	–	–	0.21%	105
2017 Q1	$5.53M	Buy	150,000 +53,500	+55%	+$1.35M	0.32%	86
2016 Q4	$1.39M	Sell	96,500 -1,500	-2%	-$26.4K	0.09%	118
2016 Q3	$2.26M	Hold	98,000	–	–	0.14%	118
2016 Q2	$1.63M	Buy	98,000 +20,000	+26%	+$403K	0.12%	120
2016 Q1	$1.24M	Buy	78,000 +7,500	+11%	+$133K	0.1%	121
2015 Q4	$2.28M	Buy	70,500 +10,500	+18%	+$455K	0.17%	107
2015 Q3	$2.53M	Buy	+60,000	New	+$2.83M	0.21%	106

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rock Springs Capital Management's GBT Position: Q3 2020 in Review

Rock Springs Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 288,279 shares — an estimated $18.2M sold.

Rock Springs Capital Management first reported a position in GBT in Q3 2015 and held it in 20 quarters. The position peaked at $21.1M in Q4 2019. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

Rock Springs Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
Rock Springs Capital Management sold 288,279 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $18.2M.
Rock Springs Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 20 quarters.
Rock Springs Capital Management's Global Blood Therapeutics, Inc. position peaked at $21.1M in Q4 2019.
229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Rock Springs Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.